推薦產品
物種活性
human
包裝
kit of 96 wells (12 strips x 8 wells)
技術
ELISA: suitable
輸入
sample type urine
sample type plasma
sample type serum
sample type cell culture supernatant(s)
assay range
inter-assay cv: <12%
intra-assay cv: <10%
sensitivity: 6 pg/mL
standard curve range: 7.373-1800 pg/mL
檢測方法
colorimetric
運輸包裝
wet ice
儲存溫度
−20°C
基因資訊
human ... AFP(174)
一般說明
AFP ELISA试剂盒用于定量测量细胞培养上清、血浆和血清中的甲胎蛋白。
應用
生化／生理作用
α-胎蛋白（AFP）可促进成胎儿和增殖中的人肝脏细胞中的脂肪酸调节。已在急性肝损伤中观察到该基因的过表达，表明活跃的肝再生。AFP与可能导致肝硬化和肝细胞癌的脂肪肝疾病（FLD）相关。它可作为HCC（肝细胞癌）的一种肿瘤标志物。
其他說明
本产品提供样本分析证书。
请在批号对应的文本框中输入单词 sample 。
请在批号对应的文本框中输入单词 sample 。
訊號詞
Warning
危險聲明
防範說明
危險分類
Met. Corr. 1
儲存類別代碼
8A - Combustible corrosive hazardous materials
閃點（°F）
Not applicable
閃點（°C）
Not applicable
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
客戶也查看了
Novel photoelectrochemical immunosensor for disease-related protein assisted by hemin/G-quadruplex-based DNAzyme on gold nanoparticles to enhance cathodic photocurrent on p-CuBi2O4 semiconductor.
Lv S, et al.
Biosensors And Bioelectronics, 96, 317-323 (2017)
Abdel Hady A Abdel Wahab et al.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 22(7), 621-628 (2016-10-30)
The incidence rate of hepatocellular carcinoma (HCC) is higher in developing countries, and most cases are associated with chronic hepatitis C virus (HCV) infection. To evaluate the circulating proteins as liver biomarkers for the identification of HCC associated with HCV
Garima Singhal et al.
Molecular metabolism, 13, 56-66 (2018-05-14)
Non-alcoholic fatty liver (NAFL) associated with obesity is a major cause of liver diseases which can progress to non-alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma (HCC). Fibroblast growth factor 21 (FGF21) plays an important role in liver metabolism and is also
Kenya Kamimura et al.
Cancers, 12(2) (2020-02-23)
Hepatocellular carcinoma (HCC) is a major global malignancy, responsible for >90% of primary liver cancers. Currently available therapeutic options have poor performances due to the highly heterogeneous nature of the tumor cells; recurrence is highly probable, and some patients develop
Gianluigi Giannelli et al.
PloS one, 15(3), e0222259-e0222259 (2020-03-27)
Transforming growth factor beta (TGF-β) signalling is involved in the development of hepatocellular carcinoma (HCC). We followed changes in biomarkers during treatment of patients with HCC with the TGF-βRI/ALK5 inhibitor galunisertib. This phase 2 study (NCT01246986) enrolled second-line patients with
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務